The Company will host a corporate update conference call on Monday, March 31, 2025 at 4:30 PM ET following its presentation of results from the CardiAMP HF Trial at the Late-Breaking Clinical Trials ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...

If we want to turn these short-term gains into sustainable change, we must fully unleash the potential of methadone-assisted treatment.

ECHS is the result of a partnership between Duke Health, Durham Tech and Durham Public Schools that received a $29.5 million ...